Becker B N, Ismail N, Becker Y T, MacDonnell R C, Helderman J H
Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA.
Semin Nephrol. 1996 Jul;16(4):353-62.
Transplant physicians in the United States continue to face an interesting problem when offering kidney transplantation as a form of renal replacement therapy to older end-stage renal disease (ESRD) patients. The limited life-expectancy of these patients and an ever-present shortage of cadaveric organs makes kidney transplantation in this population a potentially controversial issue. Early results suggested poor outcomes for cadaveric renal transplantation in middle-aged or elderly ESRD patients. Improved patient selection, changes in immunosuppression regimens, and living-related transplantation have increased the success of transplantation in these patients. Efforts to define older patients at risk for cardiovascular disease and to account for their altered immune function may further improve outcomes. However, if older ESRD patients are to be rightfully included in the patient population eligible for transplantation, then the organ shortage will inevitably worsen. A potentially intriguing solution to this problem is to expand the donor pool by including older donors. Despite data suggesting that recipients of older grafts may have shorter graft survival; older donors could readily serve as a source of kidneys for older recipients who do not require 20+ year graft survival based upon their projected lifespan. Ultimately, age alone should not serve as a contraindication to renal transplantation. In patients over the age of 60, 1-year patient and graft survival rates approach 85% and 75%, respectively. However, careful assessment of "biologic" age and comorbid illnesses should be considered when offering renal transplantation to older patients.
在美国,移植医生在为老年终末期肾病(ESRD)患者提供肾移植作为一种肾脏替代治疗形式时,仍面临一个有趣的问题。这些患者有限的预期寿命以及尸体器官一直存在的短缺,使得在这一人群中进行肾移植成为一个潜在的争议性问题。早期结果表明,中年或老年ESRD患者进行尸体肾移植的预后较差。改进的患者选择、免疫抑制方案的改变以及亲属活体移植提高了这些患者移植的成功率。确定有心血管疾病风险的老年患者并考虑其免疫功能改变的努力可能会进一步改善预后。然而,如果老年ESRD患者要被合理纳入适合移植的患者群体,那么器官短缺将不可避免地加剧。解决这个问题的一个潜在有趣的办法是通过纳入老年供体来扩大供体库。尽管有数据表明老年移植物接受者的移植物存活时间可能较短;但对于那些根据预期寿命不需要20多年移植物存活的老年受者来说,老年供体可以很容易地作为肾脏来源。最终,仅年龄本身不应作为肾移植的禁忌证。在60岁以上的患者中,1年的患者和移植物存活率分别接近85%和75%。然而,在为老年患者提供肾移植时,应考虑对“生物学”年龄和合并症进行仔细评估。